There is no single age that is medically defined as the “best age” for IVF for everyone. In general, IVF outcomes using a woman’s own eggs are more favorable at younger reproductive ages because egg quality and fertility decline with age. However, IVF can be considered throughout the reproductive years, and the appropriate timing depends on age, fertility diagnosis, ovarian reserve, reproductive history and other individual factors.
Age is particularly important because female fertility declines with increasing age, and female age is considered the strongest predictor of fecundity. Ovarian reserve tests such as AMH and antral follicle count can provide additional information, but they do not replace assessment based on age and the overall clinical picture.
If IVF is medically indicated, younger reproductive age generally provides more favorable conditions for treatment with a woman’s own eggs.
This does not mean that IVF should automatically be performed at a young age, or that treatment after 35 or 40 cannot work. IVF is a treatment for infertility and other specific reproductive circumstances, so the decision to pursue it should be based on the individual’s medical situation rather than age alone.
The important distinction is between:
These are not necessarily the same thing.
Age affects IVF primarily through changes in the number and quality of available eggs.
Ovarian reserve refers mainly to the quantity of eggs remaining in the ovaries. Egg quality is a separate concept and is more closely associated with the ability of an egg to produce a chromosomally normal embryo and ultimately a live birth.
As reproductive age increases, both ovarian reserve and egg quality tend to decline, although the degree of variation between individuals can be considerable. ASRM notes that ovarian reserve markers can help predict ovarian response and egg yield during IVF but are poor predictors of reproductive potential when considered independently of age.
This is why a normal AMH result does not necessarily mean that age-related changes in egg quality are absent.
|
Age |
What generally matters for IVF |
|
Under 35 |
Fertility is generally more favorable, with younger egg age and a lower age-related risk of chromosomal abnormalities. |
|
35–37 |
Fertility and egg quality may begin to decline, although many patients still have favorable treatment options. |
|
38–40 |
Age becomes an increasingly important factor when assessing ovarian response, embryo development and reproductive outcomes. |
|
Over 40 |
Age-related changes in egg quality and embryo chromosomal status become increasingly important, and fertility assessment may warrant more immediate attention. |
These age ranges are broad clinical categories rather than predictions of an individual’s IVF outcome. Two women of the same age can have very different ovarian reserve, reproductive histories and treatment responses.
From a biological perspective, younger age is generally associated with more favorable reproductive potential when using a woman’s own eggs.
However, IVF is not routinely recommended simply because someone is under 35.
IVF may be appropriate when there is a diagnosed fertility problem, such as tubal-factor infertility, severe male-factor infertility, certain ovulatory disorders, or other circumstances in which IVF is clinically indicated.
For someone who has no known fertility problem, undergoing IVF purely because of age is not necessarily appropriate.
The decision should follow a fertility assessment and consideration of the person’s reproductive plans.

IVF can be an effective treatment option between 35 and 40, but age becomes increasingly relevant when planning treatment.
ASRM recommends fertility evaluation after 6 months of trying for women aged 35 and older, while women over 40 may warrant more immediate evaluation and treatment.
This does not mean that every woman over 35 needs IVF.
Instead, it means that the amount of time available for evaluation and treatment may become more important because fertility continues to change with age.
A fertility assessment can help determine whether it is reasonable to continue trying naturally, consider IUI, or discuss IVF.
Yes. IVF can still be performed after 40, but outcomes using a woman’s own eggs generally become less favorable with increasing age.
Current UK HFEA data demonstrate the age-related difference clearly. In 2024, the average birth rate per embryo transferred was 38% among patients aged 18–34 compared with 8% among patients aged 43–44. These are population-level UK figures and should not be interpreted as an individual’s personal probability of success or as a prediction for any particular clinic.
NICE’s fertility guidance, updated in 2026, also recognizes the effect of age on IVF outcomes and includes specific recommendations for patients aged 40 and 41 who meet its criteria for treatment.
Therefore, being over 40 does not automatically mean that IVF is inappropriate. It does mean that treatment planning should be based on a careful assessment of the potential benefits, limitations and alternatives.
One of the most important age-related changes is the increasing likelihood of chromosomal abnormalities in eggs and embryos.
This can affect:
This is why an IVF cycle does not simply depend on how many eggs are retrieved.
A simplified way to understand the process is:
Eggs retrieved → mature eggs → fertilization → embryo development → suitable embryos → embryo transfer → pregnancy → live birth
At older reproductive ages, there may be greater loss between these stages.
No. AMH does not determine the best age for IVF.
AMH is commonly used as a marker of ovarian reserve and can help estimate how the ovaries may respond to stimulation during IVF.
However, AMH primarily provides information about ovarian quantity rather than egg quality.
ASRM states that ovarian reserve markers can help predict oocyte yield following stimulation and retrieval, but they are poor predictors of reproductive potential independently of age.
This means that two patients can have similar AMH levels but different reproductive outlooks because of differences in age and other clinical factors.
Age is only one part of a fertility assessment.
Depending on the patient’s circumstances, evaluation may include:
ASRM recommends evaluating ovulatory status, the structure and patency of the female reproductive tract and semen factors as part of an infertility evaluation.
This broader assessment is important because the appropriate treatment may be different for someone with diminished ovarian reserve, tubal-factor infertility, ovulatory dysfunction or male-factor infertility.
Not necessarily. The key is to avoid unnecessary delay when there is a reason to seek fertility treatment.
For women aged 35 and older, ASRM recommends infertility evaluation after 6 months of trying without conception. For women over 40, more immediate evaluation and treatment may be warranted.
A consultation does not automatically mean starting IVF.
It can instead answer a more useful question:
What is the most appropriate reproductive plan for me at my current age and with my current fertility profile?
Depending on the findings, that plan might involve continued natural conception, IUI, IVF, fertility preservation or another treatment approach.
IVF may be considered when there is a medical indication or when other approaches are unlikely to be appropriate or have not been successful.
Examples can include:
The exact indication matters.
For example, a woman aged 36 with blocked fallopian tubes may have a very different treatment pathway from a woman aged 36 with regular ovulation and no identified fertility problem.
The question of the “best age” can also arise when someone is considering fertility preservation rather than immediate IVF.
Age is an important consideration because eggs are stored at the biological age at which they are frozen. Younger age at egg freezing is generally associated with more favorable egg quality.
However, egg freezing should not be presented as a guarantee of future pregnancy.
ASRM emphasizes that decisions about planned oocyte cryopreservation should be based on a woman’s reproductive plans and age, rather than relying on ovarian reserve testing alone.
For someone considering fertility preservation, an individualized consultation can help explain what egg freezing can and cannot accomplish.
Yes, the interpretation of age changes when donor eggs are used.
When donor eggs are used, the age and characteristics of the egg donor become relevant to the embryos created from those eggs. NICE guidance specifically states that embryo-transfer strategy in donor-egg IVF should be based on the donor’s age.
Donor-egg IVF is not automatically necessary after a particular birthday. Whether it should be discussed depends on ovarian reserve, previous treatment, age, reproductive history and the patient’s circumstances and preferences.
No. Age is one of the strongest factors, but IVF outcomes depend on multiple clinical variables.
Important factors can include:
This is why published IVF statistics should be interpreted carefully.
A national average is not the same as an individual prognosis.
There is no single worldwide age at which IVF becomes medically impossible or inappropriate for every patient.
Access criteria and clinical practice can differ between countries, healthcare systems and clinics.
For example, NICE’s 2026 UK guidance includes specific IVF recommendations for people aged 40 or 41 who meet defined treatment criteria.
The relevant question for an individual patient is therefore not simply, “Am I too old for IVF?”
It is:
“What treatment options are medically reasonable for me at my current age and based on my fertility assessment?”
If you are considering IVF, useful questions include:
These questions can make a fertility consultation more useful because treatment decisions should be based on the complete clinical picture rather than age alone.

There is no universal “best age” for IVF, but younger reproductive age generally offers more favorable conditions for IVF using a woman’s own eggs.
The decline in fertility with age is driven not only by changes in ovarian reserve but also by age-related changes in egg quality and embryo chromosomal status. At the same time, age does not determine an individual’s outcome by itself.
If you are considering IVF, particularly from your mid-30s onward, a timely fertility assessment can help clarify your ovarian reserve, identify other fertility factors and determine whether IVF or another approach is appropriate.
If you are considering fertility treatment, you can contact Dr. Emad Darwish for an individualized fertility assessment and discussion of your options through the official Dr. Emad Darwish IVF website.
Medical disclaimer: This content is intended for general educational purposes and does not replace individualized medical assessment. Fertility treatment recommendations depend on medical history, test results, age, reproductive goals and other individual factors.
There is no single best age for IVF. IVF using a woman’s own eggs generally has more favorable outcomes at younger reproductive ages because egg quality and fertility decline with age. The appropriate timing of IVF depends on the individual’s fertility diagnosis and circumstances.
Younger age is generally associated with more favorable reproductive potential, but IVF is not routinely recommended simply because someone is under 35. IVF should be considered when there is an appropriate medical indication or fertility problem.
No. IVF remains an option after 35, although age becomes increasingly important when assessing fertility and treatment outcomes. ASRM recommends fertility evaluation after 6 months of trying without conception for women aged 35 and older.
No. IVF can still be considered after 40, although outcomes using a woman’s own eggs generally decline with increasing age. NICE’s 2026 guidance includes specific IVF recommendations for eligible patients aged 40 and 41.
No. AMH is mainly a marker of ovarian reserve and can help predict ovarian response to IVF stimulation. It does not independently measure egg quality or determine an individual’s overall reproductive potential.
If you have been trying to conceive for 6 months without success, fertility evaluation is generally recommended from age 35 onward. Earlier assessment may be appropriate when there is a known fertility risk factor.
Yes, but the probability of success generally decreases with age. The impact varies between individuals and depends on factors including ovarian reserve, embryo development, sperm factors and the cause of infertility.
Younger age at egg freezing is generally associated with better egg quality, but egg freezing does not guarantee a future pregnancy. The decision should be based on reproductive plans and age rather than ovarian reserve testing alone.
There is no single worldwide age limit that applies to every IVF patient. Regulations, healthcare systems and clinic policies differ, while medical suitability depends on the individual’s circumstances.
Contact the clinic to ask about fertility evaluation, IVF and ICSI, or to arrange an appointment with Dr. Emad Darwish El Sayed.
All Rights Reserved. Developed By Pro-Branding.